Effects of hypersecretion of growth hormone and prolactin on plasma levels of glucagon and insulin in GH3-cell-tumor-bearing rats, and the influence of bromocriptine treatment
- 1 August 1986
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 39 (7), 617-621
- https://doi.org/10.1016/0024-3205(86)90042-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Mechanism of bromocriptine-induced hyperglycaemiaLife Sciences, 1985
- Effect of MtTW15 mammosomatotropic tumors on pancreatic islet hormonesDiabetes, 1983
- Effect of Long Term Bromocriptine Treatment on Glucose Intolerance in AcromegalyHormone and Metabolic Research, 1982
- Bromocriptine and insulin secretionBioscience Reports, 1982
- THE EFFECT OF BROMOCRIPTINE ON INSULIN SECRETION AND GLUCOSE TOLERANCE IN PATIENTS WITH ACROMEGALYClinical Endocrinology, 1981
- EFFECT OF BROMOCRIPTINE, ERGOTAMINE AND OTHER ERGOT ALKALOIDS ON THE HORMONE SECRETION AND GROWTH OF A RAT PITUITARY TUMOURJournal of Endocrinology, 1980
- Prolactin: A diabetogenic hormoneDiabetologia, 1977
- Determination of total serum insulin (IRI) in insulin-treated diabetic patientsDiabetologia, 1972
- Radioimmunological determination of pancreatic and gut glucagon in plasmaDiabetologia, 1971
- Isolation, Crystallization and Amino Acid Composition of Rat GlucagonHormone and Metabolic Research, 1971